Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma

Figure 4 The prognostic value of the 5-long non-coding RNA signature for the hepatocellular carcinoma patients in the entire set (n = 370). A: Kaplan-Meier analysis of patients’ overall survival in the high-risk (n = 189) and low-risk subgroups (n = 181) for the entire set; B: The receiver operating characteristic analysis of the risk score for predicting the overall survival of the test set; C: The 5-long non-coding RNA (5-lncRNA)-based risk score distribution, patient survival status; D: Heatmap of the 5-lncRNA expression profiles in the high-risk and low-risk subgroups for the entire set.